XML 32 R22.htm IDEA: XBRL DOCUMENT
v3.20.2

Organization and Nature of Operations (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of company's subsidiaries consolidated financial statements |
Name of Subsidiary |  | Place and date of Incorporation |  | Percentage of Ownership |  | Principal Activities
Avalon Healthcare System, Inc. ("AHS") |  | Delaware May 18, 2015 |  | 100% held by AVCO |  | Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in United States of America ("USA")
Avalon (BVI) Ltd. ("Avalon BVI") |  | British Virgin Island January 23, 2017 |  | 100% held by AVCO |  | Dormant, is in process of being dissolved
Avalon RT 9 Properties LLC ("Avalon RT 9") |  | New Jersey February 7, 2017 |  | 100% held by AVCO |  | Owns and operates an income-producing real property and holds and manages the corporate headquarters
Avalon (Shanghai) Healthcare Technology Co., Ltd. ("Avalon Shanghai") |  | PRC April 29, 2016 |  | 100% held by AHS |  | Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in China
Genexosome Technologies Inc. ("Genexosome") |  | Nevada July 31, 2017 |  | 60% held by AVCO |  | Develops proprietary diagnostic and therapeutic products using exosomes
Beijing Jieteng (Genexosome) Biotech Co., Ltd. ("Beijing Genexosome") |  | PRC August 7, 2015 |  | 100% held by Genexosome |  | Provides development services for hospitals and other customers and sells developed items to hospitals and other customers in China
Avactis Biosciences Inc. ("Avactis") |  | Nevada July 18, 2018 |  | 100% held by AVCO |  | Integrate and optimize global scientific and clinical resources to further advance cellular therapies, including regenerative medicine with stem/progenitor cells as well as cellular immunotherapy including CAR-T, CAR-NK, TCR-T and others to treat certain cancers
International Exosome Association LLC ("Exosome") |  | Delaware June 13, 2019 |  | 100% held by AVCO |  | Promotes standardization related to exosome industry

X
- Definition Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedFinancialStatementsTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration